Low-Gradient Aortic Stenosis:
A Challenging Entity
Low-gradient aortic stenosis (LGAS) is a challenging entity from both a diagnostic and therapeutic standpoint.
LGAS is characterized by the concomitance of a small aortic valve area ([AVA] <1.0 cm 2 ; consistent with severe stenosis) with a low gradient (<40 mm Hg; consistent with nonsevere stenosis) at echocardiographic examination. This discordant grading situation raises an uncertainty about the severity of the stenosis and thus the indication of aortic valve replacement (AVR). There are 3 main types of LGAS: (1) classical low-flow LGAS with reduced ejection fraction (LVEF); (2) paradoxical lowflow LGAS with preserved LVEF; and (3) normal-flow LGAS ( Figure) . 1, 2 In the first 2 types, the LGAS pattern is because of the presence of a low-flow state, which is defined in the guidelines as a stroke volume index <35 mL/m 2 . 3, 4 In normalflow LGAS, the stroke volume index is normal, but the mean transvalvular flow rate (ie, stroke volume divided by LV ejection time) may nonetheless be low (<200 mL/s) because of prolonged systolic duration.
1,2 Normal-flow LGAS may also occur as a result of reduced arterial compliance, which may dampen the gradients despite normal stroke volume and mean transvalvular flow. 5 Several studies and meta-analyses have reported that AVR is associated with improved survival in patients with LGAS. 1, 2, 6, 7 In the guidelines for the management of valvular heart diseases, 3, 4 AVR is recommended (class I or IIa) in symptomatic patients with low-flow LGAS after confirmation of the presence of severe stenosis (Figure) . The 2017 European Society of Cardiology/European Association for Cardio-Thoracic Surgery guidelines also mention that the stenosis is most likely not severe in patients with normal-flow LGAS, but they do not exclude the use of additional tests to confirm stenosis severity in these patients, particularly if they are symptomatic. 3 According to recent studies, 1,2,5,8 the proportion of severe stenosis among patients with normal-flow LGAS may be as high as 40%.
See Article by Kusunose et al
In this issue of Circulation: Cardiovascular Imaging, Kusunose et al 9 present an elegant study in which they make the first proof of concept that preload stress echocardiography performed with the use of a leg massage machine may successfully increase transvalvular flow rate and therefore differentiate severe from nonsevere AS in patients with LGAS and preserved LVEF.
Confirmation of AS Severity: A Key
Step in the Management of LGAS Among patients with LGAS, 30% to 50% display nonsevere stenosis and should thus be managed conservatively. 1, 2, 8 Hence, the crucial step to determine the need for AVR in a symptomatic patient with LGAS is to confirm the presence of true-severe stenosis, which may be particularly challenging in the presence of a discordant grading at the echocardiographic examination ( Figure) . The guidelines 3, 4 recommend performing additional tests to confirm stenosis severity including (1) assessment of aortic valve morphology by transthoracic or transesophageal echocardiography, (2) dobutamine stress echocardiography (DSE), and (3) aortic valve calcium scoring by multi-slice computed tomography (Figure) .
Each of these tests has advantages and limitations. Low-dose (≤20 µg/kg per minute) DSE is particularly useful in patients with classical low-flow LGAS and reduced LVEF to assess the presence of LV flow reserve (ie, percent increase in stroke volume >20% during dobutamine) and to differentiate true-versus pseudo-severe stenosis. However, this test may remain inconclusive in a substantial proportion of patients with classical low-flow LGAS because of absent or insufficient flow reserve. 10 Furthermore, in patients with paradoxical low-flow LGAS and preserved LVEF, who often have pronounced LV concentric remodeling, small LV cavity, and advanced diastolic dysfunction, DSE may fail to significantly increase stroke volume and may be associated with adverse side effects (eg, hypotension because of impaired LV filling and LV outflow tract obstruction; Figure) .
The assessment of valve leaflet morphology and mobility by transthoracic or transesophageal echocardiography should always be part of the echocardiographic evaluation of patients with AS, and particularly those with LGAS. However, the assessment of valve leaflet morphology and mobility is qualitative or semiquantitative and is subject to inter-/intraobserver measurement variability. Furthermore, significantly reduced leaflet mobility is a sensitive but nonspecific marker of severe stenosis in patients with LGAS because these patients often have a low-flow state, which may result in incomplete opening of valve leaflets in the setting of a mildly or moderately stenotic valve (Figure) . Preload Stress Echocardiography in Low-Gradient AS Aortic valve calcification score assessed by multi-slice computed tomography is a quantitative parameter of AS anatomic severity that has been shown to strongly correlate with AS hemodynamic severity, progression rate, and outcomes. 1, 2, 8 In the 2017 edition of the European Society of Cardiology/European Association dor Cardio-Thoracic Surgery guidelines, 3 the committee has included, for the first time, this parameter as a diagnostic tool to differentiate severe from nonsevere AS in patients with LGAS. A cutoff value of >2000 AU in men and >1200 AU in women has been proposed to identify severe AS and recommend AVR in these patients. The main advantages of aortic valve calcium score are the excellent feasibility, accuracy, and reproducibility and the fact that it is independent of flow or hemodynamics and does not require the administration of any stressor or contrast agent. The disadvantages are the exposure to ionizing radiation (although low, ie, <1.5 mSv) and the potential for false-negative cases. Indeed, hemodynamic severity of AS is determined not only by valve leaflet calcification but also by fibrosis, which is not captured by multi-slice computed tomography.
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Some patients, and especially younger patients with a bicuspid valve, may have a hemodynamically severe stenosis with little or no valve calcification. 12 In such cases, the stenosis is predominantly related to the abnormal geometry of the valve orifice and the fibrotic remodeling and thickening of the valve cusps. Fortunately, there are relatively few young patients Management of low-gradient aortic stenosis (LGAS). Green square: the test has been shown to be safe and accurate to identify severe stenosis in patients with LGAS; yellow square: the test may be used but has not been well validated for this subset of patients; orange square: the test could be considered but has limited accuracy or is associated with side effects, or both. AVC indicates aortic valve calcium score; AVR, aortic valve replacement; TAVR, transcatheter AVR; TEE, transesophageal echocardiography; TTE, transthoracic echocardiography; and SAVR, surgical AVR. Adapted from Clavel et al 1 with permission. Copyright ©2017, the American College of Cardiology. Preload Stress Echocardiography in Low-Gradient AS with a bicuspid valve among the LGAS patients, in whom multi-slice computed tomography is most beneficial.
Usefulness and Limitations of Preload Stress Echocardiography in LGAS
In this issue of the journal, Kusunose et al 9 demonstrate, for the first time, the potential usefulness of preload stress echocardiography to distinguish severe versus nonsevere stenosis in patients with LGAS and preserved LVEF. On the basis of the Frank-Starling Law, an increase in preload results in an augmentation of stroke volume and thus of mean transvalvular flow rate. The advantages of preload stress echocardiography are that it is feasible in most patients and is easy and fast to execute. Moreover, it does not require the administration of any pharmacological agent. This test is more physiological than DSE and, as opposed to exercise stress echocardiography, it is applicable to symptomatic patients. Furthermore, in patients with paradoxical low-flow LGAS, preload stress may significantly increase transvalvular flow rate but with potentially less side effects than DSE. Indeed, preload stress is less likely than DSE to induce LV outflow tract obstruction, ventricular arrhythmias, and hypotension in these patients.
On the other hand, preload stress has inherent limitations. In patients with already high LV filling pressure, such as is often the case in patients with paradoxical low-flow LGAS, preload stress may fail to further increase stroke volume (Figure) . The goal of any type (ie, dobutamine, exercise, or preload) of stress echocardiography in patients with LGAS is to achieve sufficient increase in flow rate to reconcile the discordant grading (ie, small AVA with low gradient) observed at rest. To meet this goal, a minimum of 15% to 20% increase in flow rate is generally required. 10 In the present study, 9 preload stress was able to only induce a small increase in transvalvular flow rate (+11% on average). If the increase in flow achieved by stress is small (<20%), the discordant grading may persist at end of the stress test and the stenosis severity may remain indeterminate. This situation occurs in ≈30% of patients with DSE, 10 and this proportion is likely much larger with preload stress. 9 In such cases, the criteria proposed in the guidelines to identify severe AS (ie, peak stress mean gradient ≥40 mm Hg) may not be applicable because of low sensitivity (Figure) . To overcome this limitation, 1 valuable alternative is to calculate the projected AVA at normal-flow rate. 10 Given that the AVA-flow relationship is approximately linear within the low/normal transvalvular flow range, it is possible, using a linear regression, to estimate what would be the AVA at a standardized normal-flow rate of 250 mL/s. This level of flow corresponds to the median value of the normal-flow range (200-300 mL/s). The projected AVA can easily be calculated from the resting values of AVA and flow and the change in AVA divided by the change in flow during stress (ie, an estimate of the slope of the AVA-flow regression line). 1, 10 Interestingly, Kusunose et al 9 found a strong agreement between the projected AVA measured during preload stress and that measured during dobutamine stress. Furthermore, a projected AVA indexed to body surface area <0.72 cm 2 /m 2 was strongly associated with the risk of cardiac events (2-fold increase per 0.1 cm 2 decrease in indexed projected AVA). These findings provide further strong validation of the projected AVA measured during stress echocardiography for risk stratification of LGAS.
Kusunose et al 9 found that the best cut point of indexed projected AVA (<0.72 cm 2 /m 2 ) to predict cardiac events is larger than that reported in previous studies (<0.55 cm 2 / m 2 ). 13 This difference may be explained by the fact that the present study 9 included asymptomatic or equivocal symptomatic patients, whereas previous studies 13 in LGAS with preserved LVEF predominantly included patients with symptoms and more advanced disease. Stress echocardiography is clinically relevant in symptomatic patients with LGAS because its result may influence therapeutic decision making. So when using dobutamine or preload stress echocardiography, it seems more appropriate to apply the cutoff values of projected AVA (<1.0 cm 2 or < 0.55 cm 2 /m 2 ) previously reported to identify true-severe stenosis in symptomatic LGAS (Figure) .
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Implications for the Management of LGAS
In symptomatic patients with LGAS, the first step is to confirm the accuracy of the measurements of stroke volume, AVA, and gradients ( Figure) . The second step is to identify the type of LGAS, that is, classical low flow, paradoxical low flow, or normal flow. The third step is to select, depending on the type of LGAS, the most suitable test(s) to confirm stenosis severity (Figure) . Preload stress echocardiography may be used preferably in patients with normal-flow or paradoxical lowflow LGAS and normal or mildly/moderately increased filling pressures (E/eʹ ratio <14). If the test performed in step number 3 confirms the presence of severe stenosis, the last step is to select surgical or transcatheter AVR.
Conclusions
LGAS is an important and challenging entity that should receive special attention. AVR has been shown to improve outcomes in these patients. However, the 2 key steps that need to be accomplished to take a decision with regards to the indication of AVR in a symptomatic patient with LGAS are to confirm (1) accuracy of echocardiographic measurements and (2) presence of severe stenosis. With the study of Kusunose et al, 9 preload stress echocardiography now becomes another option in the armamentarium of tests that can be considered to identify severe stenosis and therefore confirm the indication of AVR in symptomatic LGAS.
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